Baumer

Baumer FCF/Debt

The Free Cash Flow to Debt Ratio of Baumer (BALM4.SA) as of Nov 9, 2026 is 136.88 %. In the previous year, Free Cash Flow to Debt Ratio was 92.90 % — a change of 47.34% (higher).

FCF/Debt

136.88 %

YoY

47.34%

Last updated:

Free Cash Flow to Debt Ratio of Baumer is 2024 136.88 % . Free Cash Flow to Debt Ratio of Baumer was 2023 92.90 % . It decreases by 47.34% higher compared to the previous year.

The Baumer FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2017
12.75 BRL
Jan 1, 2018
-17.91 BRL
Jan 1, 2019
22.86 BRL
Jan 1, 2020
111.03 BRL
Jan 1, 2021
59.40 BRL
Jan 1, 2022
-11.48 BRL
Jan 1, 2023
92.90 BRL
Jan 1, 2024
136.88 BRL
The Baumer FCF/Debt history
YEARFCF/DebtYoY
136.88 %+47.34%
92.90 %-909.10%
-11.48 %-119.33%
59.40 %-46.50%
111.03 %+385.68%
22.86 %-227.61%
-17.91 %-240.54%
12.75 %-348.65%
-5.13 %-195.44%
5.37 %+83.19%
2.93 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

Free Cash Flow to Debt Ratio of Baumer is 136.88 % in 2024.

Free Cash Flow to Debt Ratio of Baumer changed from 92.90 % to 136.88 %, representing a 47.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Baumer since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Baumer with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Baumer

All Key Metrics — Baumer